Last Posted: Aug 02, 2018
- Impacts of GRIN3A, GRM6 and TPH2 genetic polymorphisms on quality of life in methadone maintenance therapy population.
Wang Ruey-Yun et al. PloS one 2018 13(7) e0201408 - Single Nucleotide Polymorphisms in TAOK3 Are Associated with High Opioid Requirement for Pain Management in Patients with Advanced Cancer Admitted to a Tertiary Palliative Care Unit.
Gutteridge Timothy et al. Journal of pain and symptom management 2018 Jul - The Genomics of Neonatal Abstinence Syndrome.
Cole F Sessions et al. Frontiers in pediatrics 2017 5176 - Effects of Single Nucleotide Polymorphisms on Surgical and Postsurgical Opioid Requirements: A Systematic Review and Meta-Analysis.
Choi Siu-Wai et al. The Clinical journal of pain 2017 Dec 33(12) 1117-1130 - An Ambitious Research Plan to Help Solve the Opioid Crisis
- The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati Bilel et al. Pharmacogenomics 2018 May - Confronting the Opioid Epidemic
- Pharmacogenetics of Opioid Use Disorder Treatment.
Crist Richard C et al. CNS drugs 2018 Apr - NIH launches HEAL Initiative, doubles funding to accelerate scientific solutions to stem national opioid epidemic
NIH News Release, Apr 4, 2018 - Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.
Lloyd Renae A et al. Pain medicine (Malden, Mass.) 2017 Dec 18(12) 2369-2387
.png)
No hay comentarios:
Publicar un comentario